Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

BigBear.ai Holdings

Clear Channel Outdoor Holdings

Nikola

Oatly

Purple Innovation

Virgin Galactic

Given the recent market volatility, many traders are trying to make money in penny stocks. With low prices and elevated volatility, penny stocks could be a great way for traders to cash in on breaking news and rapid changes in market sentiment.

Stock Market Crash Warning: Don't Get Caught Holding These 7 Penny Stocks

Tilray Brands and Bitcoin are fairly risky investments. Tilray's ambitions are large, but obstacles are proving to be persistent.

Tilray Brands Stock vs. Bitcoin: Which Investment Is Worth the Risk?

Aurora Cannabis

Canopy Growth

Cronos Group

AdvisorShares Pure US Cannabis ETF

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

American Homes 4 Rent

Cannabis company stocks skyrocketed Tuesday following multiple reports marijuana will be reclassified to a less dangerous drug schedule, which could broaden the substance's medical usage and cut down regulations tied to it.

Cannabis Stocks Spike Following Reports Marijuana Will Be Reclassified As Less Dangerous Drug

SNDL Inc.

The DEA officially agreed to recommend rescheduling cannabis from a Class I to a Class III drug. While it doesn't legalize cannabis, the measure has the potential to be hugely impactful to U.S. multi-state operators.

Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

AdvisorShares Pure Cannabis ETF 

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

Cannabis stocks surged on Tuesday afternoon following multiple media reports that the US Drug Enforcement Administration will approve the reclassification of marijuana as a lower-risk drug. The news was first reported by the Associated Press, which cited five people familiar with the matter.

Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Cambria Cannabis ETF

Roundhill Cannabis ETF

The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.

Mario Naric On Canada's Shakeout Phase

The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press reported on Tuesday, citing five people familiar with the matter.

US drug enforcers to ease restrictions on cannabis, AP reports

Curaleaf Holdings, Inc.

Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled substance. For more than 50 years, cannabis has been a Schedule I substance under federal law, in the same bucket as heroin and fentanyl.

Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA

Breckenridge Brewery Launches New Ridge Runner IPA inspired by the untamed beauty of Colorado's trails and adventurous outdoor lifestyle behind the brand.

Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner'

Tilray's position in Canada is strong, but the market north of the border doesn't inspire confidence. The company could benefit from recent developments in Germany, although there will be some obstacles.

Where Will Tilray Stock Be in 1 Year?

It's been a wild journey for cannabis stocks in the last eight years. There have been phases of euphoria that have quickly fizzled out.

3 Cannabis Stocks That Could Be Multibaggers in the Making: April Edition

10 Barrel Brewing Wins Innovation in Craft Brewing Award and Sweeps German-Style Sour Ale Category with Gold, Silver, and Bronze Medals Green Flash Brewing Wins Bronze in Juicy or Hazy Pale Ale Category NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq | TSX: TLRY), a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10 Barrel's Brewmaster, Tonya Cornett an industry trailblazer, was recognized with the esteemed Russell Schehrer Award for Innovation in Craft Brewing.

Tilray Brands Celebrates Big Wins at the Craft Brewer's Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World

Trump Media & Technology Group Corp

GameStop

Nordstrom

Paramount Global

Express

If you're wondering what stocks to sell this quarter, you're in the right place. Nothing lasts forever, not even stocks.

7 Stocks That Could Be Heading Six-Feet Under

ATLANTA, April 25, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY), today announced a design refresh to make the Sweetwater brand more impactful, cohesive, and memorable to consumers. SweetWater's updated portfolio of beers is available now across the Southeast and in select national markets.

Sweetwater Brewing Unveils Modern Rebrand

The cannabis industry has rapidly become a significant sector within the stock market, attracting a diverse array of investors. Yet marijuana stocks are notorious for their volatility, influenced heavily by regulatory changes and political dynamics. This article explores essential strategies for investing in cannabis stocks during these fluctuating conditions. Plus highlights how political developments can impact the way most marijuana stocks trade. Navigating the marijuana stock market requires savvy investment strategies that account for its inherent unpredictability.

Top Canadian Marijuana Stocks To Invest In For Big Gains

Marijuana legalization may be inching closer in the U.S. but it just became a reality in Germany. As of April 1, Germans can now legally grow up to three marijuana plants for personal use.

Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop

Tilray Brands is burning through cash, and that may intensify if new growth opportunities arise for the business. Alcohol has been a growing part of its operations, but priorities may change if Tilray decides to go all-in on cannabis.

3 Reasons Tilray Brands Investors Shouldn't Assume U.S. Marijuana Legalization Would Fix the Stock's Problems

Montauk will donate proceeds of Project 4:20 to the Surfrider Foundation, a non-profit dedicated to the protection and enjoyment of the world's oceans.

Montauk Brewing's Project 4:20 IPA Returns to Support Surfrider Foundation

Tilray Brands and Canopy Growth are often the default options for investors looking for cannabis stocks. But those are risky, cash-burning businesses counting on the hopes that the U.S. legalizes marijuana soon.

The Best Cannabis Stock to Invest $1,000 in Right Now

NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, is proud to announce a series of 420-events, celebrations, and environmental initiatives in the U.S. across Tilray's craft beer brands. Celebrating community, craft brewing excellence, and environmental stewardship, Tilray's craft brands, including SweetWater Brewing , Blue Point Brewing , Redhook Brew , 10 Barrel Brewing , Breckenridge Brewery , and Montauk Brewing , are hosting memorable events and launching specialty brews that reflect each brand's commitment to sustainability, creativity, and the spirited celebration of 420.

Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country

With April 20 approaching (a notable cannabis celebration indeed), thoughts may turn to investing in marijuana stocks. However, beyond the symbolic date, imminent catalysts could drive significant growth in this sector for speculators and those wishing well on the providers of sticky icky turning higher.

High Hopes: Could 4/20 Light Up a Cannabis Stock Rally?

As we move into mid-April 2024, Canadian marijuana stocks are capturing the attention of investors, given the ongoing developments and shifts in the global cannabis market. Stocks like Tilray, Canopy Growth, and Aurora Cannabis are notable for their robust international operations and diverse product lines. Tilray, for example, has expanded its presence in the U.S. through acquisitions like MedMan, positioning it well to capitalize on potential market expansions. Canopy Growth has made significant strides in operational efficiency, achieving considerable cost savings and enhancing its financial health, which speaks to its ability to navigate a complex market landscape.

April 2024's Hot Picks: Top Canadian Cannabis Stocks To Watch Now

News for Tilray Brands Stock (TLRY)